17:21 EST PTC Therapeutics (PTCT) to replace SanDisk (SNDK) in S&P 600 at open on 11/28
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTCT:
- Strong Market Penetration and Strategic Pricing Propel PTC Therapeutics to a Buy Rating
- PTC Therapeutics price target raised to $50 from $44 at Goldman Sachs
- PTC Therapeutics’ Earnings Call Highlights Success and Challenges
- PTC Therapeutics price target raised to $82 from $70 at RBC Capital
- PTC Therapeutics price target raised to $63 from $50 at TD Cowen